Optimizing Patient Engagement in a Novel Pain Management Initiative (OPEN) (OPENtext)
Visão geral do estudo
Descrição detalhada
Chronic pain is a condition that affects the most fundamental aspects of quality of life. Treatment for chronic pain is challenging and usually takes the form of opioid medication therapy. But chronic opioid therapy is also associated with high rates of emergency department use, drug diversion, addiction, and unintentional overdose deaths. The new RI Medicaid Chronic Pain Initiative (CPI) targets patients who are both high emergency department users and experiencing chronic pain. In the CPI, patients can be prescribed an integrated treatment plan of massage, chiropractic, or acupuncture therapies. This is a novel approach to chronic pain care, but retention and patient engagement are low. It is important to understand why involvement in the CPI is low, how to improve the patient experience, and how to support the prescribed CAM therapies.
This study has two aims: The first is to identify what helps to keep patients involved with the CPI program and to identify features of an ideal text-message-based program for people enrolled in the CPI. The second aim is to develop the text-message-based program (OPENtext), then find out how useful this intervention is compared to a patient navigator intervention (OPENnav) for increasing patient engagement, improving patient's motivation to manage their chronic pain, and improving patient confidence in self-managing their chronic pain condition.
Investigators will conduct qualitative interviews with patients, providers, and administrators. Goals of the interviews will be: to understand the patient experience in the CPI, including experiences with the navigation approach currently in place; to identify barriers and facilitators to CPI participation; and to learn how technology-especially cell phone text-messaging-could help support pain care and CPI engagement. These interviews will help develop a text-message-based intervention and provide feedback to existing patient navigator programming. Next, investigators will develop and test the text-message patient support intervention that will contain patient-identified topics and concerns that emerge from the qualitative interviews and topic areas discussed by a stakeholder Advisory Board. Theories of behavior change will be used to help with message development, and patients will take part in helping to test and fine-tune the intervention. Last, investigators will compare the text-message and patient navigation interventions in a randomized controlled study with 200 patients over a six-month period. Investigators will see which approach helps patients increase their involvement in the CPI and better manage their chronic pain. If successful, chronic pain patients across Medicaid programs could benefit from use of the patient navigation or the text-message intervention.
Tipo de estudo
Inscrição (Real)
Estágio
- Não aplicável
Contactos e Locais
Locais de estudo
-
-
Rhode Island
-
Providence, Rhode Island, Estados Unidos, 02903
- Rhode Island Hospital
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Descrição
Inclusion Criteria:
- Enrolled in the Rhode Island Medicaid Chronic Pain Initiative program
Exclusion Criteria:
- Do not speak English
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Pesquisa de serviços de saúde
- Alocação: Randomizado
- Modelo Intervencional: Atribuição Paralela
- Mascaramento: Solteiro
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Experimental: OPENtext
OPENtext will target cognitive, affective, and behavioral strategies through a single, brief in-person assessment, followed by 12 weeks of theoretically-informed text messages, a core set of information organized in a 'frequently asked questions' structure, interactive peer support, static resources on key patient-identified topics, and a library of peer stories accessible throughout the study period.
|
Participants will receive 12 weeks of daily text messages sent from an automated system.
The text messages will assist participants in managing their chronic pain.
|
|
Comparador Ativo: OPENnav
Peer Navigation is currently offered to some individuals in this Medicaid population but not all.
Peer navigators interact with patients by phone/text and at home visits.
Efforts focus on drivers of a patient's ED use, and may include providing or identifying patient support, improving health literacy, assisting with transportation vouchers, health education, family support, accessing housing services, and orienting to other community support services.
|
Particpants will be linked with a RIPN PEER Navigator who will assisted them in managing their health care
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Change in Engagement
Prazo: Once per month for 6 months
|
Investigators will capture change in engagement in the CPI program based on utilization of services per month, derived from AMI's administrative records.
For the purposes of this study, engagement will be defined as having one or more visits to a CAM provider in a given month.
|
Once per month for 6 months
|
|
Readiness to Change
Prazo: At baseline, 3 months, and 6 months post-randomization
|
The Pain Stages of Change Questionnaire (PSOCQ) will be used to measure change in patient's self-reported engagement in the CPI and in the intervention group.
|
At baseline, 3 months, and 6 months post-randomization
|
|
Change in Self-Efficacy
Prazo: At baseline, 3 months, and 6 months post-randomization
|
To measure patient's change in confidence of their ability to self-manage their condition, investigators will use the Chronic Pain Self Efficacy Scale (CPSS).
|
At baseline, 3 months, and 6 months post-randomization
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Pain Severity
Prazo: At baseline, 3 months, and 6 months post-randomization
|
To assess the severity of pain and the impact of pain on daily functions, investigators will use the Brief Pain Inventory short form (BPI), which is commonly used in clinical trials and has documented validity, reliability, and responsiveness to change.
|
At baseline, 3 months, and 6 months post-randomization
|
|
Quality of Life
Prazo: At baseline, 3 months, and 6 months post-randomization
|
Investigators will use the Short Form-12 (SF-12)103, a global measure of patient quality of life with well-established psychometrically sound properties across many disease areas and populations, including chronic pain patients.
The SF-12 is responsive to interventions, and is currently being used as the key CPI patient evaluation measure by AMI.
|
At baseline, 3 months, and 6 months post-randomization
|
|
Pain Medication Use
Prazo: At baseline, 3 months, and 6 months post-randomization
|
Schedule II/III opioid medication utilization will derive from the RI Department of Health (HEALTH)'s Prescription Monitoring Program (PMP) database.
|
At baseline, 3 months, and 6 months post-randomization
|
|
Likelihood of Misusing Opioid Medication
Prazo: At baseline, 3 months, and 6 months post-randomization
|
The SOAPP-R and COMM are quick and easy-to-use, designed to help providers evaluate the patients' relative risk for developing problems when placed on long-term opioid therapy (SOAPP-R) or to monitor chronic pain patients on opioid therapy (COMM).
As a screening tool, the SOAPP-R and the COMM are recommended by SAMHSA in the treatment of chronic pain in patients with histories of or at risk of substance use disorder.
|
At baseline, 3 months, and 6 months post-randomization
|
|
Safety and Aberrant Pain Medication Use Behaviors
Prazo: At baseline, 3 months, and 6 month post-randomization
|
Investigators will examine patient ED utilization from the health plans' (UH,NH) claims data and prevalence and incidence of aberrant opioid medication use (i.e.,"dr.
shopping") from the RI PMP database.
|
At baseline, 3 months, and 6 month post-randomization
|
|
Acceptance & Satisfaction
Prazo: At 9-month follow up
|
Patients will be asked to rate intervention utility and content (relevance, interest) using 5-point Likert scales.
|
At 9-month follow up
|
Colaboradores e Investigadores
Patrocinador
Colaboradores
Investigadores
- Investigador principal: Traci Green, PhD, MSc, Inflexxion, Inc., Brown University, and Rhode Island Hospital
- Cadeira de estudo: Megan Ranney, MD, The Miriam Hospital and Brown University
- Cadeira de estudo: Elizabeth Donovan, PhD, Independent consultant
Publicações e links úteis
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Real)
Conclusão Primária (Real)
Conclusão do estudo (Real)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Estimativa)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- IHS -1306-02960
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .